NCT06094127View on ClinicalTrials.gov

Zenith Thoracic Alpha (ZTA) Post-Market Data Collection

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

October 1, 2029

Study Completion Date

October 1, 2034

Conditions
Thoracic Aortic AneurysmPenetrating Aortic Ulcer
Interventions
DEVICE

Endovascular aortic treatment

Use of ZTA to treat diseases in the descending thoracic aorta, such as thoracic aortic aneurysm and penetrating aortic ulcer.

Trial Locations (10)

20132

ACTIVE_NOT_RECRUITING

IRCCS Ospedale San Raffaele, Milan

20246

ACTIVE_NOT_RECRUITING

Universitätsklinikum Hamburg-Eppendorf, Hamburg

21079

RECRUITING

CHU Dijon Bourgogne, Dijon

40138

ACTIVE_NOT_RECRUITING

IRCCS-University Hospital Sant'Orsolo Polyclinic, Bologna

48145

ACTIVE_NOT_RECRUITING

St. Franzikus Hospital Munster, Münster

59000

ACTIVE_NOT_RECRUITING

Centre Hospitalier Regional Universitaire de Lille, Lille

81377

ACTIVE_NOT_RECRUITING

Universitätsklinikum der LMU München, München

92350

ACTIVE_NOT_RECRUITING

Hopital Marie Lannelongue Groupe Hospitalier Pairs St Joseph, Le Plessis-Robinson

6202 AZ

ACTIVE_NOT_RECRUITING

Maastricht University Medical Center, Maastricht

6500 HB

RECRUITING

Radboud UMC, Nijmegen

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY